T-knife Therapeutics Alternatives & Competitors
12 companies similar to T-knife Therapeutics — T-knife uses a mouse platform to create human TCRs for cancer treatment without...
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...
London, United Kingdom
Artios
Taking control of the DNA Damage Response (DDR)
Cambridge, United Kingdom
Focal Medical, Inc. (acquired by Continuity Biosciences)
We are developing novel targeted therapeutic products based on our innovative local drug-d...
Cary, United States
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
Track all T-knife Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
TScan Therapeutics
Unleash Immunity
Waltham, United States
Faeth Therapeutics
Unlocking the power of metabolism to treat cancer.
United States
PhotonPharma
An immuno-oncology company unleashing the body to fight cancer
Fort Collins, United Stat...
Bicycle Therapeutics
Precision-Guided Therapeutics
Cambridge, United Kingdom
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Immune-Onc Therapeutics
Science at Our Core. Patients in Our Hearts.
Palo Alto, United States
Context Therapeutics
Advancing T Cell Engagers for Solid Tumors
Philadelphia, United Stat...
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
London, United Kingdom
About T-knife Therapeutics
T-knife uses a mouse platform to create human TCRs for cancer treatment without modification.
Development of T Cell Therapies, Clinical Research and Trials, Biological Engineering
Cancer Patients with Solid Tumors, Healthcare Providers, Oncologists
TCR-T Cell Therapy, Human TCR Development, Cancer Treatment, HuTCR Mouse Platform, Tumor-Specific TCRs, Solid Tumors, Cancer Testis Antigens, Oncoviral Antigens, Tumor-Driving Neoantigens, Adoptive T Cell Therapy, Gene Therapy, Immuno-Oncology, Tumor Immunology, TCR Generation, TCR Characterization
B2B, B2C, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches T-knife Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at T-knife Therapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.